Toggle navigation
Home
Search
Services
Blog
Contact
About
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin
Hipple Cancer Research Corporation, Dayton, OH, United States
Search 58 grants from Martin Murphy
Search grants from Hipple Cancer Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanism and application of male determination in aedine mosquitoes
Lipoprotein Structure and Function by Individual Particle Electron Tomography
Regulation of Urothelial Cell Behavior by Sparc
CRCNS: Extracting Dynamical Structure Embedded in Motor Preparatory Activity
A Phase I Study of the Garft Inhibitor AG2034 in Patients with Advanced Cancer
Recently added grants:
Inflammatory microenvironment in brain metastasis
Understanding the Adoption and Impact of New Risk Assessment Technologies in Prostate Cancer Care
Leveraging tumor registries and pathology specimens to facilitate genetic testing and traceback for ovarian cancer
Pro-tumor functions of neutrophils in squamous cell lung cancer
Artificial Intelligence driven prediction of brain metastasis from primary tumor sites at diagnosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase II (N44)
Project #
N44CM027361-000
Application #
3609932
Study Section
Project Start
1992-08-01
Project End
1994-07-31
Budget Start
1992-08-01
Budget End
1993-07-31
Support Year
Fiscal Year
1992
Total Cost
Indirect Cost
Institution
Name
Hipple Cancer Research Corporation
Department
Type
DUNS #
City
Dayton
State
OH
Country
United States
Zip Code
45439
Related projects
NIH 1993
N44 CM
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin / Hipple Cancer Research Corporation
NIH 1992
N44 CM
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin / Hipple Cancer Research Corporation
Comments
Be the first to comment on Martin Murphy's grant